306 related articles for article (PubMed ID: 28003592)
21. Characterization of CTX-M-type extended-spectrum beta-lactamase-producing diarrheagenic Escherichia coli isolates in the Republic of Korea during 2008-2011.
Kim JS; Kim J; Kim SJ; Jeon SE; Oh KH; Cho SH; Kang YH; Han SY; Chung GT
J Microbiol Biotechnol; 2014 Mar; 24(3):421-6. PubMed ID: 24509253
[TBL] [Abstract][Full Text] [Related]
22. Improved detection of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli in input and output samples of German biogas plants by a selective pre-enrichment procedure.
Schauss T; Glaeser SP; Gütschow A; Dott W; Kämpfer P
PLoS One; 2015; 10(3):e0119791. PubMed ID: 25799434
[TBL] [Abstract][Full Text] [Related]
23. ESBL-producing Escherichia coli isolated from children with acute diarrhea - antimicrobial susceptibility, adherence patterns and phylogenetic background.
Franiczek R; Sobieszczańska B; Turniak M; Kasprzykowska U; Krzyzanowska B; Jermakow K; Mokracka-Latajka G
Adv Clin Exp Med; 2012; 21(2):187-92. PubMed ID: 23214282
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
Kao CY; Udval U; Huang YT; Wu HM; Huang AH; Bolormaa E; Yan JJ; Urangoo Z; Batbaatar G; Khosbayar T; Wu JJ
J Microbiol Immunol Infect; 2016 Oct; 49(5):692-700. PubMed ID: 26194952
[TBL] [Abstract][Full Text] [Related]
25. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?
Ewers C; Bethe A; Stamm I; Grobbel M; Kopp PA; Guerra B; Stubbe M; Doi Y; Zong Z; Kola A; Schaufler K; Semmler T; Fruth A; Wieler LH; Guenther S
J Antimicrob Chemother; 2014 May; 69(5):1224-30. PubMed ID: 24398338
[TBL] [Abstract][Full Text] [Related]
26. Sequence type ST131 and ST10 complex (ST617) predominant among CTX-M-15-producing Escherichia coli isolates from Nigeria.
Aibinu I; Odugbemi T; Koenig W; Ghebremedhin B
Clin Microbiol Infect; 2012 Mar; 18(3):E49-51. PubMed ID: 22192452
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
[TBL] [Abstract][Full Text] [Related]
28. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Japan: emergence of CTX-M-15-producing E. coli ST131.
Kuroda H; Yano H; Hirakata Y; Arai K; Endo S; Kanamori H; Yamamoto H; Ichimura S; Ogawa M; Shimojima M; Komatsu M; Jonai T; Itagaki S; Nonomiya Y; Suwabe A; Kaku M
Diagn Microbiol Infect Dis; 2012 Oct; 74(2):201-3. PubMed ID: 22796185
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
[TBL] [Abstract][Full Text] [Related]
30. Occurrence of ESBL-Producing Escherichia coli in Livestock and Farm Workers in Mecklenburg-Western Pomerania, Germany.
Dahms C; Hübner NO; Kossow A; Mellmann A; Dittmann K; Kramer A
PLoS One; 2015; 10(11):e0143326. PubMed ID: 26606146
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia.
Yasir M; Ajlan AM; Shakil S; Jiman-Fatani AA; Almasaudi SB; Farman M; Baazeem ZM; Baabdullah R; Alawi M; Al-Abdullah N; Ismaeel NA; Shukri HA; Azhar EI
Sci Rep; 2018 Oct; 8(1):14847. PubMed ID: 30287889
[TBL] [Abstract][Full Text] [Related]
32. Wild Birds, Frequent Carriers of Extended-Spectrum β-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types.
Alcalá L; Alonso CA; Simón C; González-Esteban C; Orós J; Rezusta A; Ortega C; Torres C
Microb Ecol; 2016 Nov; 72(4):861-869. PubMed ID: 26687342
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany.
Pietsch M; Eller C; Wendt C; Holfelder M; Falgenhauer L; Fruth A; Grössl T; Leistner R; Valenza G; Werner G; Pfeifer Y;
Vet Microbiol; 2017 Feb; 200():130-137. PubMed ID: 26654217
[TBL] [Abstract][Full Text] [Related]
34. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
[TBL] [Abstract][Full Text] [Related]
35. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.
Nicolas-Chanoine MH; Gruson C; Bialek-Davenet S; Bertrand X; Thomas-Jean F; Bert F; Moyat M; Meiller E; Marcon E; Danchin N; Noussair L; Moreau R; Leflon-Guibout V
J Antimicrob Chemother; 2013 Mar; 68(3):562-8. PubMed ID: 23143897
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial resistance patterns of extended spectrum β-lactamase -producing enteropathogenic Escherichia coli strains isolated from children.
Karami P; Bazmamoun H; Sedighi I; Mozaffari Nejad AS; Aslani MM; Alikhani MY
Arab J Gastroenterol; 2017 Dec; 18(4):206-209. PubMed ID: 29233495
[TBL] [Abstract][Full Text] [Related]
37. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
38. Subgrouping of ESBL-producing Escherichia coli from animal and human sources: an approach to quantify the distribution of ESBL types between different reservoirs.
Valentin L; Sharp H; Hille K; Seibt U; Fischer J; Pfeifer Y; Michael GB; Nickel S; Schmiedel J; Falgenhauer L; Friese A; Bauerfeind R; Roesler U; Imirzalioglu C; Chakraborty T; Helmuth R; Valenza G; Werner G; Schwarz S; Guerra B; Appel B; Kreienbrock L; Käsbohrer A
Int J Med Microbiol; 2014 Oct; 304(7):805-16. PubMed ID: 25213631
[TBL] [Abstract][Full Text] [Related]
39. Detection of plasmid-borne extended-spectrum β-lactamase (ESBL) genes in Escherichia coli isolates from bovine mastitis.
Freitag C; Michael GB; Kadlec K; Hassel M; Schwarz S
Vet Microbiol; 2017 Feb; 200():151-156. PubMed ID: 27566885
[TBL] [Abstract][Full Text] [Related]
40. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
